Antiviral effects of modified Dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model
Graphical abstract
Introduction
Respiratory syncytial virus (RSV) is a major cause of pneumonia and bronchiolitis in infants, young children and even in the elderly. The global annual infection figure for RVS is estimated to be 64 million. In the USA, RSV directly causes 18 000–75 000 hospitalisations and up to 1900 deaths annually, and contributes to another 17 000 deaths (Paes, 2003, Krilov et al., 2010). However, the ineffectiveness of vaccine is one of the major barriers for RSV prevention (Graham, 2011) and only a relatively nonspecific antiviral agent, ribavirin, which is reported to be obvious myelocytotoxic, is used for treatment (Narayana et al., 2002, Maggon and Barik, 2004). Thus, the development of novel anti-RSV drugs is still warranted.
Traditional herbal medicines have been used as remedies against infectious diseases for thousands of years due to their significant anti-inflammatory, antimicrobial and antiviral activities with no or few adverse effects (Ma et al., 2002, Ojwang et al., 2005, Sharma et al., 2009). Especially, therapeutic effects of the mixed formulas of Chinese herbal medicines are based on the synergic action of its mass constituents (Glatthaar-Saalmüller et al., 2011, Wang et al., 2011, Chang et al., 2012).
Dingchuan decoction, which is described in a famous traditional Chinese medicine (TCM) monograph Shesheng Zhongmiaofang in Ming Dynasty of China, has been used for approximately 500 years for treatment of cough, asthma and viral pneumonia. According to clinical experience, a modified Dingchuan decoction (MDD) was developed to ameliorate the complicated pathologic state of bronchiolitis in the acute phases, which is prepared with Salviae miltiorrhizae Radix, Scutellariae Radix, Farfarae Flos and Ephedrae Herba. Recently, MDD is widely used in east China as an herbal recipe for its efficiency in treating cough, asthma, pneumonia and bronchiolitis, but its actual mechanisms in the therapeutic process remains unclear. Therefore, this study is to investigate protective potentials of MDD on the levels of inflammatory cytokines, viral loads and expressions of NF-κB and TLR4 in lung tissues of RSV-infected mice.
Section snippets
Virus, cell and reagents
Human RSV (A strain) was donated by Professor Yiyu Lu from Zhejiang Center for Disease Control and Prevention, China. The virus was propagated in Hep-2 Cells for the preparation of a large stock of the virus. Hep-2 Cells were grown in DMEM (Sigma Co.) containing Eagle's balanced salt solution supplemented with 10% FBS, 100 U/mL of penicillin, 25 µg/mL of gentamicin, and 2 mM of l-glutamine (growth medium). RSV-infected cells were maintained in DMEM supplemented with 1% FBS (maintenance medium).
Results and discussion
This study demonstrated that MDD was effective in the protection of RSV infection. Aqueous extracts from 4 herbs and their mixture were studied to detect antiviral activity against RSV. As shown in Table 2, the 5 tested samples exhibited anti-RSV activity to different extents. MDD showed obvious antiviral activity with IC50 value 27.2 μg/mL, which was among those of 4 herbal extracts. It indicated that the therapeutic effect of the herbal medicine MDD was based on the synergic action of its mass
Acknowledgments
This work was a project supported by Scientific Research Fund of Zhejiang Provincial Education Department (NO. Y201017708). We thank Professor Yi-yu Lu for technical help in the animal experiment.
References (30)
- et al.
Acute and subchronic oral toxicity assessment of the aqueous extract from the stem bark of Erythrina senegalensis DC (Fabaceae) in rodents
Journal of Ethnopharmacology
(2011) - et al.
Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract
Journal of Ethnopharmacology
(2011) - et al.
Ge-Gen-Tang has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines
Journal of Ethnopharmacology
(2012) - et al.
TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model
Vaccine
(2009) - et al.
C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine
Vaccine
(2007) - et al.
TAK1 regulates NF-κB and AP-1 activation in airway epithelial cells following RSV infection
Virology
(2011) - et al.
Antiviral activity in vitro of two preparations of the herbal medicinal product Sinupret® against viruses causing respiratory infections
Phytomedicine
(2011) - et al.
The anti-inflammatory effect of tussilagone, from Tussilago farfara, is mediated by the induction of heme oxygenase-1 in murine macrophages
International Immunopharmacology
(2009) - et al.
Prevalence of respiratory syncytial virus (RSV) risk factors and cost implications of immunoprophylaxis to infants 32 to 35 weeks gestation for health plans in the United States
Value in Health
(2010) - et al.
Determination of gentiopicroside, mangiferin, palmatine, berberine, baicalin, wogonin and glycyrrhizin in the traditional Chinese medicinal preparation Sann-Joong-Kuey-Jian-Tang by high-performance liquid chromatography
Journal of Chromatography A
(1996)